Detalles de la búsqueda
1.
Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn's Disease: A Multicenter Study.
Clin Gastroenterol Hepatol
; 22(5): 1058-1066.e2, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38122958
2.
Effectiveness of Reinduction and/or Dose Escalation of Ustekinumab in Crohn's Disease: A Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol
; 20(12): 2728-2740.e1, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34628078
3.
Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases.
Gastroenterology
; 161(1): 107-115.e3, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33744307
4.
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 20(1): 126-135, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33039584
5.
Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease.
Dig Dis Sci
; 66(8): 2564-2569, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32875527
6.
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 18(13): 2952-2961.e8, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32062041
7.
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 17(8): 1533-1540.e2, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30268561
8.
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 17(12): 2497-2505.e1, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30625408
9.
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
Gastroenterology
; 155(3): 687-695.e10, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29857091
10.
Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
Am J Gastroenterol
; 113(12): 696, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30390030
11.
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
Am J Gastroenterol
; 113(9): 1345, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29946178
12.
Pathologist, Meet Picasso! Virtual Chromoendoscopy for Detecting Histologic Remission in Ulcerative Colitis.
Gastroenterology
; 160(5): 1469-1472, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33508287
13.
Correction to: Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease.
Dig Dis Sci
; 66(9): 3216, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33555517
14.
Temporary Faecal Diversion for Refractory Perianal and/or Distal Colonic Crohn's Disease in the Biologic Era: An Updated Systematic Review with Meta-analysis.
J Crohns Colitis
; 18(3): 375-391, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37707480
15.
Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases.
Aliment Pharmacol Ther
; 53(3): 374-382, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33314269
16.
Predicting Response to Vedolizumab in Inflammatory Bowel Disease.
Front Med (Lausanne)
; 7: 76, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32300596
17.
In the absence of head-to-head trials, what do real world studies tell us about the comparative effectiveness of biologics in Crohn's disease.
Best Pract Res Clin Gastroenterol
; 38-39: 101619, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31327408
18.
Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes.
Inflamm Bowel Dis
; 25(11): 1854-1861, 2019 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31050734
19.
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 24(11): 2461-2467, 2018 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29788240
20.
Editorial: risk of pneumonia in IBD-reading between the lines!
Aliment Pharmacol Ther
; 54(11-12): 1490-1491, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34741329